EVITA - A double-blind, vehicle controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity.
Author | |
---|---|
Abstract | :
Acne-like skin rash is a frequently occurring adverse event associated with drugs against the epidermal growth factor receptor. This randomized vehicle-controlled study investigated the addition of vitamin K1 cream to doxycycline in patients with metastatic colorectal cancer treated with cetuximab. |
Year of Publication | :
2018
|
Journal | :
Annals of oncology : official journal of the European Society for Medical Oncology
|
Date Published | :
2018
|
ISSN Number | :
0923-7534
|
URL | :
https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdy015
|
DOI | :
10.1093/annonc/mdy015
|
Short Title | :
Ann Oncol
|
Download citation |